Increasing Operational Capacity and Reducing Costs of Rituximab Administration: A Costing Analysis-Reference-Cited by-同舟云学术

Increasing Operational Capacity and Reducing Costs of Rituximab Administration: A Costing Analysis

Published:2020-04-21 Issue:5 Volume:2 Page:261-268
ISSN:2578-5745
Container-title:ACR Open Rheumatology
language:en
Short-container-title:ACR Open Rheuma

Author:

Wallace Zachary S.¹^ORCID,Harkness Tyler²,Blumenthal Kimberly G.¹,Choi Hyon K.¹^ORCID,Stone John H.¹^ORCID,Walensky Rochelle P.¹

Affiliation:

1. Massachusetts General Hospital and Harvard Medical School Boston Massachusetts

2. Massachusetts General Hospital Boston Massachusetts

Funder

Rheumatology Research Foundation

National Institute of Arthritis and Musculoskeletal and Skin Diseases

Massachusetts General Hospital

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/acr2.11133

Reference34 articles.

1. Centers for Medicare and Medicaid Serves.Dashboard. URL:https://www.cms.gov/Research‐Statistics‐Data‐and‐Systems/Statistics‐Trends‐and‐Reports/Medicare‐Geographic‐Variation/GV_Dashboard.html

2. RITUXAN (rituximab) [package insert].San Francisco:Genentech Inc.;2019.

3. Rapid infusion rituximab in combination with corticosteroid-containing chemotherapy or as maintenance therapy is well tolerated and can safely be delivered in the community setting

4. Use of a Pharmacy Protocol to Convert Standard Rituximab Infusions to Rapid Infusion Shortens Outpatient Infusion Clinic Visits

5. Treatment Delays Associated With Prior Authorization for Infusible Medications: A Cohort Study

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The potential of Bruton’s tyrosine kinase (BTK) inhibitors in the pharmacotherapeutic management of immune and dermatological disease;Expert Opinion on Pharmacotherapy;2024-08-12

2. Evolution of Therapy for ANCA-Associated Vasculitis with Kidney Involvement;Kidney360;2023-11-06

3. Comparative Effectiveness of Rituximab‐ Versus Cyclophosphamide‐Based Remission Induction Strategies in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis for the Risk of Kidney Failure and Mortality;Arthritis & Rheumatology;2023-07-04

4. Mechanisms of Action and Limitations of Monoclonal Antibodies and Single Chain Fragment Variable (scFv) in the Treatment of Cancer;Biomedicines;2023-06-01

5. Contemporary management challenges in seropositive NMOSD;Journal of Neurology;2022-07-11